Jason Shand Robins serves as Interim CFO at OCULAR THERAPEUTIX, INC, where they oversee executive responsibilities. Since joining the company, Jason Shand Robins has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 20, 2026 involved receiving (via award) 33,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 20, 2026 | OCUL | $0 | Award | 33,000 | $N/A | Discretionary |
Jason Shand Robins currently holds 33,000 shares of OCULAR THERAPEUTIX, INC (OCUL), valued at approximately $0. This represents their equity stake as Interim CFO.
Based on SEC Form 4 filings, Jason Shand Robins has been a net neutral trader of OCUL stock. They have purchased $0 and sold $0 worth of shares.
Jason Shand Robins's most recent insider trade was on Jan 20, 2026, when they sold 33,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted